Consistent with this notion, pharmacological inhibition of at least three class I PI(3)K isoforms was shown to be required effectively to block GM-CSF-mediated survival effect in circulating neutrophils derived from both healthy individuals and acutely exacerbated patients with chronic obstructive pulmonary disease (COPD) [57]. This evidence concerns the gene PIK3CD and chronic obstructive pulmonary disease.